Issue navigation
Volume 192, Issue 4, April 2025
Systematic Review and Meta Analysis
Metabolic syndrome in childhood, adolescent, and young adult cancer survivors: recommendations for surveillance from the International Late Effects of Childhood Cancer Guideline Harmonization Group
Selina R van den Oever and others
European Journal of Endocrinology, Volume 192, Issue 4, April 2025, Pages S27–S40, https://doi.org/10.1093/ejendo/lvaf046
Original Research
Big data determination and validation of reference range for 24-h urine cortisol by liquid chromatography-mass spectrometry
Gregory A Kline and others
European Journal of Endocrinology, Volume 192, Issue 4, April 2025, Pages 327–334, https://doi.org/10.1093/ejendo/lvaf054
Circulating miR-20a-5p as a biomarker associated with cabergoline responsiveness in patients with hyperprolactinemia and pituitary adenomas
Yang Jong Lee and others
European Journal of Endocrinology, Volume 192, Issue 4, April 2025, Pages 335–345, https://doi.org/10.1093/ejendo/lvaf025
Impaired accuracy of the dexamethasone suppression test after bariatric surgery: implications for post-surgical cortisol interpretation
Anna Casteràs and others
European Journal of Endocrinology, Volume 192, Issue 4, April 2025, Pages 346–355, https://doi.org/10.1093/ejendo/lvaf053
Age-related differences in the clinical features and management of pituitary apoplexy: a cohort study
Esteban Cordero Asanza and others
European Journal of Endocrinology, Volume 192, Issue 4, April 2025, Pages 356–363, https://doi.org/10.1093/ejendo/lvaf056
Germline-derived GNAS-Gsα variants associated with both gain-of-function and loss-of-function phenotypes
Atilano Carcavilla and others
European Journal of Endocrinology, Volume 192, Issue 4, April 2025, Pages 364–372, https://doi.org/10.1093/ejendo/lvaf006
Cardiovascular status in chronic hypoparathyroidism: a systematic cross-sectional assessment in 168 patients
Carmina Teresa Fuss and others
European Journal of Endocrinology, Volume 192, Issue 4, April 2025, Pages 373–384, https://doi.org/10.1093/ejendo/lvaf023
Reassessing the role of the p.(Arg304Gln) missense AIP variant in pituitary tumorigenesis
Paul Benjamin Loughrey and others
European Journal of Endocrinology, Volume 192, Issue 4, April 2025, Pages 385–397, https://doi.org/10.1093/ejendo/lvaf044
Prioritization of predisposition genes for familial non-medullary thyroid cancer by whole-genome sequencing
Aayushi Srivastava and others
European Journal of Endocrinology, Volume 192, Issue 4, April 2025, Pages 398–407, https://doi.org/10.1093/ejendo/lvaf045
Autoimmune diseases in 3812 Danish transgender persons and 38 120 cisgender controls before and after transgender care: a register-based cohort study
Dorte Glintborg and others
European Journal of Endocrinology, Volume 192, Issue 4, April 2025, Pages 408–417, https://doi.org/10.1093/ejendo/lvaf051
Identification of hypertension subtypes using microRNA profiles and machine learning
Smarti Reel and others
European Journal of Endocrinology, Volume 192, Issue 4, April 2025, Pages 418–428, https://doi.org/10.1093/ejendo/lvaf052
Gender-affirming hormone therapy and its impact on myocardial mass and cardiac function: a prospective magnetic resonance cohort study on transgender men and women
Carola Deischinger and others
European Journal of Endocrinology, Volume 192, Issue 4, April 2025, Pages 429–436, https://doi.org/10.1093/ejendo/lvaf057
Urea-stimulated copeptin: a novel diagnostic approach in polyuria polydipsia syndrome
Sven Lustenberger and others
European Journal of Endocrinology, Volume 192, Issue 4, April 2025, Pages 437–444, https://doi.org/10.1093/ejendo/lvaf058
Mortality in Cushing's syndrome: declining over 2 decades but remaining higher than the general population
Amit Akirov and others
European Journal of Endocrinology, Volume 192, Issue 4, April 2025, Pages 445–455, https://doi.org/10.1093/ejendo/lvaf059
High-intensity interval training improves insulin sensitivity in individuals with prediabetes
Pernille Mensberg and others
European Journal of Endocrinology, Volume 192, Issue 4, April 2025, Pages 456–465, https://doi.org/10.1093/ejendo/lvaf004
Identification of metabolite biomarkers for pancreatic neuroendocrine tumours using a metabolomic approach
Arnaud Jannin and others
European Journal of Endocrinology, Volume 192, Issue 4, April 2025, Pages 466–480, https://doi.org/10.1093/ejendo/lvaf055
Deleterious variants in intolerant genes reveal new candidates for self-limited delayed puberty
Raíssa C Rezende and others
European Journal of Endocrinology, Volume 192, Issue 4, April 2025, Pages 481–490, https://doi.org/10.1093/ejendo/lvaf061
How ready are endocrine scientists to share retrospective clinical data for research: a perspective from the European Network for the Study of Adrenal Tumors
Antoan Stefan Sojat and others
European Journal of Endocrinology, Volume 192, Issue 4, April 2025, Pages 491–509, https://doi.org/10.1093/ejendo/lvaf005
Letters
Differential cardiovascular risks of menopausal hormone therapy: insights from a Korean cohort
Qingbo Li and others
European Journal of Endocrinology, Volume 192, Issue 4, April 2025, Pages L17–L18, https://doi.org/10.1093/ejendo/lvaf040
Letter to the editor: sociodemographic, lifestyle, and medical factors associated with calculated free testosterone concentrations in men: individual participant data meta-analyses
Judith A P Bons and others
European Journal of Endocrinology, Volume 192, Issue 4, April 2025, Pages L19–L20, https://doi.org/10.1093/ejendo/lvaf075
Advertisement intended for healthcare professionals
Advertisement intended for healthcare professionals